Facebook Linkedin Twitter
Home News & Features Page 547

News & Features

CellMax Life's CMxTM circulating tumor cell (CTC) platform and liquid biopsy panel will be used by Medigen Biotech in upcoming clinical trials of its cell therapy candidates for cancers
Molecular Dx

Medigen to Use CellMax Life CTC Blood Test in Trials of Cancer Cell Therapies

Inside Precision Medicine Staff Writer -
0
An electron micrograph of DNA packed on nucleosomes. Black brackets highlight individual nucleosomes
Molecular Dx

Epigenomic Packaging of Blood’s Cell-Free DNA Reveals Biological Age

Inside Precision Medicine Staff Writer -
0
Exome sequencing designed to identify the gene responsible for chronic kidney disease has a direct impact on treatment for most patients
Molecular Dx

Study Recommends Genomic Testing as ‘Clinically Essential’ in Chronic Kidney Disease

Inside Precision Medicine Staff Writer -
0
GenMark Diagnostics has won FDA 510(k) market clearance for a pair of molecular diagnostic panel assays based on its ePlex Blood Culture Identification software platform
Molecular Dx

GenMark Wins FDA 510(k) Clearances for Fungal Pathogen, Gram-Positive Panels

Inside Precision Medicine Staff Writer -
0
The Novo Nordisk Foundation has approved a grant of DKK 990 million ($151.3 million) over 4-1/2 years to establish and operate a National Genome Centre
Molecular Dx

Novo Nordisk Foundation Commits $151M toward Denmark’s National Genome Centre

Inside Precision Medicine Staff Writer -
0
Sequence DNA.
Molecular Dx

Indivumed Parnters with IMCB on Asian Multiomics Cancer Database for Oncology

Inside Precision Medicine Staff Writer -
0
Young man smoking a joint
Molecular Dx

Cannabis Use May Cause Epigenetic Changes to Sperm

Inside Precision Medicine Staff Writer -
0
The research institute founded and headed by J. Craig Venter
News & Features

J. Craig Venter Wins Dismissal of Lawsuit by Company He Co-Founded

Alex Philippidis -
0
Biocept will apply Prognos’ artificial intelligence (AI) platform toward the use of its clinical laboratory diagnostics for precision oncology
Informatics

Biocept to Use Prognos’ AI Platform in Precision Oncology Collaboration

Inside Precision Medicine Staff Writer -
0
Bristol-Myers Squibb will partner with Boston Medical Center to identify and analyze potential sensitivity and resistance markers in patients treated with standard-of-care checkpoint inhibitors
News & Features

Bristol-Myers Squibb, Boston Medical Partner on Cancer I-O Biomarker Study

Inside Precision Medicine Staff Writer -
0
1...546547548...731Page 547 of 731

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine